Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Korea University
With
The Korean Society of Ginseng
Thirty-five female outpatients aging from 18 to 65 years, who were remitted from major depression with residual symptoms (Montgomery Asberg Depression Rating Scale, MADRS ≤ 12), were given Korean red ginseng at doses of 3g / day during 8 weeks.
Age
18–55
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Outpatients who met Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria for major depressive disorder.
Those who are in remission, which is defined as a MADRS score 8 on two consecutive visits at a 4-week interval.
Their primary psychiatric clinician determined that they would benefit from an adjuvant treatment of Korean red ginseng for residual symptoms.
You may not be if
Those who have a history of substance abuse or dependence within 1 month.
Those who have clinically significant abnormal laboratory values or any other abnormal baseline laboratory findings considered by psychiatrists to be indicative of conditions that might affect the study results.
Those who have a past history of hypersensitivity or intolerance to Korean red ginseng.
Those who participated in clinical trials within 1 month before entering the study entry.
Those who are pregnant or are breast feeding.
Those who have a immediate risk of harming self or others or history of suicide attempts in the year before the screening precluded inclusion in the study.
The patients unable/unlikely to comprehend/follow the protocol.
Clareo Health | Efficacy Study of Korean Red Ginseng to Treat Depression
